Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.82 USD | +2.84% | +5.67% | +33.29% |
Valuation
Fiscal Period: December | 2024 | 2025 | 2026 |
---|---|---|---|
Capitalization 1 | 1,705 | - | - |
Enterprise Value (EV) 1 | 1,678 | 1,609 | 1,486 |
P/E ratio | -271 x | 7.68 x | 5.66 x |
Yield | - | - | - |
Capitalization / Revenue | 10.5 x | 5.82 x | 4.33 x |
EV / Revenue | 10.3 x | 5.49 x | 3.78 x |
EV / EBITDA | 1,344 x | 6.26 x | 3.96 x |
EV / FCF | 105 x | 15.8 x | 7.86 x |
FCF Yield | 0.95% | 6.34% | 12.7% |
Price to Book | 22.9 x | 8.49 x | 4.81 x |
Nbr of stocks (in thousands) | 90,577 | - | - |
Reference price 2 | 18.82 | 18.82 | 18.82 |
Announcement Date | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 59.22 | 22.33 | - | - | 27.96 | 162.2 | 293 | 393.7 |
EBITDA 1 | - | - | - | - | -136.1 | 1.248 | 257.1 | 375 |
EBIT 1 | -24.11 | 5.815 | -85.55 | -98.56 | -137.8 | -32.15 | 73.06 | 150.9 |
Operating Margin | -40.72% | 26.04% | - | - | -492.97% | -19.82% | 24.93% | 38.34% |
Earnings before Tax (EBT) 1 | -38.58 | -5.082 | -93.14 | -111.4 | -160.8 | -37.55 | 67.67 | 144.5 |
Net income 1 | -33.23 | 7.028 | -77.33 | -137.5 | -160.3 | -32.62 | 79.45 | 159.1 |
Net margin | -56.11% | 31.47% | - | - | -573.17% | -20.11% | 27.11% | 40.4% |
EPS 2 | - | - | - | - | - | -0.0694 | 2.452 | 3.324 |
Free Cash Flow 1 | - | -48.83 | -77.34 | -71.02 | - | 16 | 102 | 189 |
FCF margin | - | -218.64% | - | - | - | 9.87% | 34.81% | 48.01% |
FCF Conversion (EBITDA) | - | - | - | - | - | 1,281.6% | 39.67% | 50.4% |
FCF Conversion (Net income) | - | - | - | - | - | - | 128.39% | 118.83% |
Dividend per Share 2 | - | - | - | - | - | - | - | - |
Announcement Date | 12/03/20 | 09/03/21 | 16/03/22 | 29/03/23 | 29/02/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | 1.496 | 7.014 | 19.45 | 25.9 | 36.19 | 45.56 | 54.55 | 61.57 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | -25.66 | -23.14 | -28.63 | -26.34 | -16.96 | -23.04 | -28.3 | -49.54 | -35.11 | -24.9 | -21.05 | -11.98 | -3.457 | 3.803 | 6 |
Operating Margin | - | - | - | - | - | - | - | -3,311.56% | -500.57% | -128% | -81.3% | -33.09% | -7.59% | 6.97% | 9.75% |
Earnings before Tax (EBT) 1 | -27.1 | -26.64 | -30.75 | -33.25 | -20.08 | -27.36 | -31.36 | -64.34 | -36.18 | -28.89 | -22.2 | -13.26 | -4.867 | 2.26 | 4.9 |
Net income 1 | -22 | -22.3 | -26.42 | -63.44 | -20.15 | -27.45 | -30.78 | -64.43 | -36.27 | -28.79 | -21.26 | -12.09 | -3.629 | 3.903 | 4.4 |
Net margin | - | - | - | - | - | - | - | -4,306.95% | -517.17% | -147.98% | -82.08% | -33.42% | -7.97% | 7.15% | 7.15% |
EPS 2 | - | - | - | - | - | - | - | - | - | - | -0.0132 | -0.0142 | -0.0163 | -0.0256 | 0.5212 |
Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 08/11/21 | 16/03/22 | 09/05/22 | 09/08/22 | 09/11/22 | 29/03/23 | 04/05/23 | 09/08/23 | 08/11/23 | 29/02/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 57.5 | - | - | 32.8 | - | - | - | - |
Net Cash position 1 | - | 93.2 | 13.9 | - | 72.4 | 27.1 | 95.5 | 218 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | -48.8 | -77.3 | -71 | - | 16 | 102 | 189 |
ROE (net income / shareholders' equity) | - | - | - | - | - | -7.77% | 171% | 113% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share 2 | - | - | - | - | - | 0.8200 | 2.220 | 3.910 |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | 0.03 | 0.1 | 0.03 | 0.72 | - | 4.81 | 9.1 | 12.2 |
Capex / Sales | 0.05% | 0.44% | - | - | - | 2.96% | 3.1% | 3.09% |
Announcement Date | 12/03/20 | 09/03/21 | 16/03/22 | 29/03/23 | 29/02/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.29% | 1.7B | |
+26.08% | 662B | |
+22.60% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 289B | |
+13.68% | 234B | |
+4.43% | 198B | |
-10.80% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- AVDL Stock
- Financials Avadel Pharmaceuticals plc